共 50 条
- [1] Mini-hyper-CVD plus inotuzumab ozogamicin (InO), with or without blinatumomab (Blina), in older patients with newly diagnosed Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (ALL): Updates from a phase II trialJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Nasnas, Cedric ChristopheJabbour, EliasHaddad, FadiShort, Nicholas JamesNasr, Lewis FadyMacaron, WalidZoghbi, MarianneRavandi, FarhadJain, NitinKadia, Tapan M.Daver, Naval GuastadBorthakur, GautamDinardo, Courtney DentonJacob, JovittaRoy, EdithLoiselle, ChristopherMilton, AnnaRivera, JuanGarris, RebeccaKantarjian, Hagop M.
- [2] Updated Results from a Phase II Study of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaBLOOD, 2021, 138Short, Nicholas J.Kantarjian, HagopRavandi, FarhadHuang, XuelinJain, NitinKadia, Tapan M.Khoury, Joseph D.Jorgensen, Jeffrey L.Wang, Sa A.Alvarado, YesidBurger, Jan A.Daver, NavalBorthakur, GautamDiNardo, Courtney D.Konopleva, MarinaPemmaraju, NaveenGarcia-Manero, GuillermoWierda, William G.Kornblau, Steven M.Jacob, JovittaKwari, MonicaRausch, Caitlin R.Loiselle, ChristopherMilton, AnnaRivera, JuanGarris, RebeccaO'Brien, Susan M.Jabbour, Elias J.
- [3] A Phase II Study of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia: Updated Results and Predictors for OutcomesBLOOD, 2022, 140 : 11679 - 11682Nasnas, PatriceJabbour, EliasShort, NicholasRavandi, FarhadHuang, XuelinJain, NitinKadia, Tapan M.Alvarado, YesidBurger, Jan A.Daver, NavalBorthakur, GautamDiNardo, Courtney D.Konopleva, MarinaGarcia-Manero, GuillermoWierda, William G.Jacob, JovittaDeen, WuliamatuKwari, MonicaLoiselle, ChristopherRoy, EdithMilton, AnnaRivera, JuanGarris, RebeccaKantarjian, Hagop
- [4] A phase II study of hyper-CVAD with blinatumomab (blina) and inotuzumab ozogamicin (INO) for newly diagnosed Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (ALL)JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Short, Nicholas JamesJabbour, EliasJain, NitinHaddad, FadiMacaron, WalidYilmaz, MusaFerrajoli, AlessandraKadia, Tapan M.Valero, Yesid AlvaradoMaiti, AbhishekNasr, Lewis FadyZoghbi, MarianneNasnas, Cedric ChristopheGarris, RebeccaZhao, MinKonopleva, MarinaRavandi, FarhadKantarjian, Hagop M.
- [5] Phase 2 Trial of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Patients with Newly Diagnosed Philadelphia ChromosomeNegative B-Cell Acute Lymphoblastic LeukemiaBLOOD, 2023, 142Jen, lWei-YingJabbour, EliasHaddad, Fadi G.Short, Nicholas J.Jain, NitinKadia, Tapan M.Daver, NavalBorthakur, GautamNasr, LewisDiNardo, Courtney D.Zoghbi, MarianneJacob, JovittaRoy, EdithLoiselle, ChristopherMilton, AnnaRivera, JuanGarris, RebeccaRavandi, FarhadKantarjian, Hagop M.
- [6] Reduced-Intensity Chemotherapy with Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II StudyBLOOD, 2020, 136Short, Nicholas J.Kantarjian, Hagop M.Ravandi, FarhadHuang, XuelinJain, NitinKadia, Tapan M.Khoury, Joseph D.Jorgensen, Jeffrey L.Wang, Sa A.Alvarado, YesidBurger, Jan A.Daver, NavalBorthakur, GautamDiNardo, Courtney D.Konopleva, MarinaPemmaraju, NaveenGarcia-Manero, GuillermoWierda, William G.Kornblau, Steven M.Jacob, JovittaRostykus, MeaganKwari, MonicaRausch, Caitlin R.Loiselle, ChristopherMilton, AnnaRivera, JuanGarris, RebeccaO'Brien, Susan M.Jabbour, Elias
- [7] Chemoimmunotherapy with Inotuzumab Ozogamicin Combined with Mini-Hyper-CVD, with or without Blinatumomab, for Newly Diagnosed Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II StudyBLOOD, 2018, 132Short, Nicholas J.Jabbour, Elias J.Ravandi, FarhadHuang, XuelinJain, NitinSasaki, KojiPemmaraju, NaveenDaver, Naval G.Khoury, Joseph DavidJorgensen, Jeffrey L.Alvarado, YesidKonopleva, Marina Y.Garcia-Manero, GuillermoKadia, Tapan M.Yilmaz, MusaBorthakur, GautamBurger, Jan A.Kornblau, Steven M.Wierda, William G.DiNardo, Courtney D.Ferrajoli, AlessandraNasnas, PatriceJacob, JovittaGarris, Rebecca E.O'Brien, Susan M.Kantarjian, Hagop M.
- [8] Updated Results of a Phase II Study of Reduced-Intensity Chemotherapy with Mini-Hyper-CVD in Combination with Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic LeukemiaBLOOD, 2019, 134Short, Nicholas J.Kantarjian, Hagop M.Ravandi, FarhadHuang, XuelinJain, NitinSasaki, KojiKhouri, RitaDaver, Naval G.Pemmaraju, NaveenKhoury, Joseph D.Jorgensen, Jeffrey L.Alvarado, YesidKonopleva, Marina Y.Garcia-Manero, GuillermoKadia, Tapan M.Yilmaz, Musa E.Borthakur, Gautam M.Burger, Jan A.Kornblau, Steven M.Wierda, William G.DiNardo, Courtney D.Ferrajoli, AlessandraJacob, JovittaRostykus, MeaganGarris, RebeccaWard, MarygraceHuang, BinruEncarnacion, CorabelleLoiselle, ChristopherO'Brien, Susan M.Jabbour, Elias
- [9] A phase II study of hyper-CVAD with sequential blinatumomab (Blina), with or without inotuzumab ozogamicin (INO), in adults with newly diagnosed B-cell acute lymphoblastic leukemia (ALL).JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Short, Nicholas JamesKantarjian, Hagop M.Ravandi, FarhadYilmaz, MusaKadia, Tapan M.Thompson, Philip A.Konopleva, MarinaFerrajoli, AlessandraJain, NitinSasaki, KojiValero, Yesid AlvaradoBorthakur, GautamDinardo, Courtney DentonOhanian, MaroMacaron, WalidGarris, RebeccaZhao, MinKwari, MonicaLoiselle, ChristopherJabbour, Elias
- [10] Updated Results of the Combination of Mini-Hyper-CVD with Inotuzumab Ozogamicin and Blinatumomab in Patients with Relapsed/Refractory B-Cell ALLBLOOD, 2024, 144 : 2811 - 2812Habib, DianeKantarjian, Hagop M.Haddad, Fadi G.Short, Nicholas J.Jain, NitinSenapati, JayastuChien, Kelly S.Garcia-Manero, GuillermoKomrokji, ZenaKadia, Tapan M.Daver, NavalDinardo, Courtney D.Sasaki, KojiGarris, RebeccaRavandi, FarhadJabbour, Elias